Biomedical Systems, Center for Diagnostic Imaging partner

Biomedical Systems has partnered with the Center for Diagnostic Imaging (CDI) to provide pharmaceutical companies, biotechnology companies and contract research organizations a single-source option for clinical research requiring the use of imaging technology and analysis.
   
Biomedical Systems Centralized Imaging Services is dedicated to the execution of centralized imaging data acquisition, analysis, and management for pharmaceutical clinical trials Phase I-IV. Biomedical Systems can acquire and process data in a multitude of modalities including: MRI, PET, angiography, echocardiography, x-ray, nuclear, and CT. The company's Pharmaceutical Division offers the option of combining multiple centralized diagnostic core lab services under one umbrella for study protocols that have an additional need for ECGs, holter, spirometry, and ambulatory blood pressure monitoring.
   
CDI's 32 facilities can be used as either primary or additional investigative sites by sponsors for clinical studies. CDI will provide access to more than 100 radiologists trained in a number of disciplines that can serve as blinded readers, expert consultants or as investigators.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.